Literature DB >> 25525764

Does Therapeutic Drug Monitoring of Ribavirin in HCV Genotype 3 Treatment With Sofosbuvir and Ribavirin Still Have a Role?

Etienne Brochot1, Sandra Bodeau, Gilles Duverlie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25525764     DOI： 10.1097/FTD.0000000000000161

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN： 0163-4356            Impact factor:   3.681


× No keyword cloud information.
  3 in total

1.  Ribavirin-induced anaemia reduced tacrolimus level in a hepatitis C patient receiving haemodialysis.

Authors:  Hin-Yee Liu; Catherine Yuen Shan Cheung; Susan Elizabeth Cooper
Journal:  BMJ Case Rep       Date:  2018-04-18

2.  Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy.

Authors:  Pierre Pradat; Victor Virlogeux; Marianne Maynard; Mathilde Leclercq; Giorgiana Hatu; Majid Amiri; Fanny Lebosse; Patrick Miailhes; Fabien Zoulim; Marie-Claude Gagnieu; François Bailly
Journal:  Hepat Mon       Date:  2015-09-01       Impact factor: 0.660

3.  Influence of Ribavirin Serum Levels on Outcome of Antiviral Treatment and Anemia in Hepatitis C Virus Infection.

Authors:  Thomas Kuntzen; Sereina Kuhn; Daniela Kuntzen; Burkhardt Seifert; Beat Müllhaupt; Andreas Geier
Journal:  PLoS One       Date:  2016-07-07       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.